Skip to main content

Exclusive-Thousands turn to Wegovy copies each month as FDA considers shortage status

(Reuters) - More than 200,000 prescriptions for copies of Novo Nordisk (NYSE:NVO)'s weight-loss drug Wegovy are getting filled by U.S. patients each … Source
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.